Diabetic Macular Edema Clinical Trials

552 clinical trials for Diabetic Macular Edema across international registries, including 43 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) — RECRUITING · PHASE1
• CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME — RECRUITING · PHASE3
• COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME — RECRUITING · PHASE3
• Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME) — RECRUITING · PHASE1
• A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated — RECRUITING · PHASE1
• A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy. — RECRUITING · PHASE1
• Home- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCT — RECRUITING · NA
• Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema — RECRUITING · PHASE3
• Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab — RECRUITING · NA
• Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections — RECRUITING · PHASE4
• Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema — RECRUITING · PHASE3
• Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients — RECRUITING · PHASE1
• Kamuvudine-9 (K9) in Diabetic Macular Edema — RECRUITING · PHASE1
• Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema — RECRUITING · NA
• Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant — RECRUITING · NA
• Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy — RECRUITING · NA
• Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema — RECRUITING · PHASE2
• MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema — RECRUITING · PHASE1
• High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy — RECRUITING · PHASE4
• Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification — RECRUITING
• Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema — RECRUITING · PHASE2
• A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema — RECRUITING · PHASE3
• Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema — RECRUITING · PHASE4
• Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients — RECRUITING · NA
• Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME) — RECRUITING · PHASE2
• Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales — RECRUITING
• Implementation of the Intravitreal Injection Administered by Nurses — RECRUITING
• A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME — RECRUITING · PHASE2
• EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema — RECRUITING · PHASE1
• Aflibercept in Recurrent or Persistent CNV — RECRUITING
• Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin — RECRUITING · PHASE2
• Gene Therapy for DME — RECRUITING · PHASE1
• Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema — RECRUITING · NA
• Gene Therapy for Diabetic Macular Edema — RECRUITING · PHASE1
• TREAT & EXTEND VERSUS FIXED DOSING WITH FARICIMAB FOR MANAGEMENT OF DIABETIC MACULAR EDEMA: A PRAGMATIC, MULTI-CENTER, OPEN-LABEL, RANDOMIZED, CONTROLLED TRIAL — RECRUITING
• A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE MASKED, ACTIVE COMPARATOR CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7200220 IN COMBINATION WITH RANIBIZUMB ADMINISTERED INTRAVITREALLY IN PATIENTS WITH DIABETIC MACULAR EDEMA — RECRUITING · PHASE2
• A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE MASKED, ACTIVE COMPARATOR CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7200220 ADMINISTERED INTRAVITREALLY IN PATIENTS WITH DIABETIC MACULAR EDEMA — RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE-MASKED, ACTIVE-CONTROLLED PHASE 2/3 STUDY OF THE EFFICACY AND SAFETY OF HIGH-DOSE AFLIBERCEPT IN PATIENTS WITH DIABETIC MACULAR EDEMA — RECRUITING · PHASE2
• A MULTICENTER, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLERABILITY OF FARICIMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA — RECRUITING
• A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATOR-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RO6867461 IN PATIENTS WITH DIABETIC MACULAR EDEMA (RHINE) — RECRUITING · PHASE3
• A 24-WEEK, RANDOMIZED, SINGLE-MASKED, MULTICENTER, PHASE IV STUDY TO COMPARE SYSTEMIC VEGF LEVELS FOLLOWING MONTHLY INTRAVITREAL INJECTIONS OF 0.5 MG RANIBIZUMAB VERSUS 2 MG AFLIBERCEPT UNTIL WEEK 24 IN PATIENTS WITH VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR EDEMA (TIDE DME) — RECRUITING · PHASE4
• INTRAVITRAOUS ANTI-VEGF TREATMENT FOR PREVENTION OF VISION THREATENING DIABETIC RETINOPATHY IN EYES AT HIGH RISK (PROTOCOL W) VERSION 1.0 — RECRUITING
• CYTOKINE LEVELS IN PATIENTS WITH PERSISTENT DIABETIC MACULAR EDEMA FOLLOWING RANIBIZUMAB THERAPY TREATED WITH TRIAMCINOLONE ACETONIDE: AN INTERVENTIONAL PROSPECTIVE STUDY — RECRUITING
• NA — COMPLETED · PHASE3
• A 12-month, two-armed, randomized, double-masked, multicenter, Phase IIIb study assessing the efficacy and safety of laser photocoagulation as adjunctive to Ranibizumab intravitreal injections vs. laser photocoagulation monotherapy in patients with visual impairment due to diabetic macular edema followed by a 12 month follow up period — TERMINATED · PHASE3
• Comparison of the efficacy of treatment of retinal macular inflammation due to diabetes with ozurdex or with ozurdex plus laser treatment in the area. — OTHER · PHASE4
• A 2 year randomized, single-masked, multicenter, controlled phase IIIb trial assessing the Efficacy and safety of 0.5 mg ranibizumab in two “treat and extend” treatment algorithms vs. 0.5 mg ranibizumab as needed in patients with macular edema and visual Impairment secondary to diabetes mellitus — COMPLETED · PHASE3
• Efficacy and safety of dexamethasone nanoparticles eye drops in diabetic macular edema. — COMPLETED · PHASE2
• Evaluation of Iluvien for the treatment of DME — ACTIVE_NOT_RECRUITING · PHASE4
• Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study) — ACTIVE_NOT_RECRUITING

Refine this search